APTEVO THERAPEUTICS INC (APVO:NASDAQ)

$3.94 0 (0%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 87

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed APTEVO THERAPEUTICS INC (APVO:NASDAQ) News Sources

Mipletamig Delivers Compelling 86% Clinical Benefit Rate and No CRS as Evaluable AML Patient Data increases by Nearly 50%

10-03-2026

yahoo.com

Aptevo to Participate in March 2026 Conferences

19-03-2026

yahoo.com

Aptevo Therapeutics (APVO) Upgraded to Buy: Here's Why

10-04-2026

yahoo.com

Aptevo Reports 87% Clinical Benefit and 81% Remission in 31 Evaluable Frontline AML Patients Through Cohort 5, Substantially Outperforming Benchmark; RAINIER on Track for 2026 Completion and Phase 2 Dose Selection

06-05-2026

yahoo.com

Aptevo Therapeutics Provides a 1Q26 Business Update; RAINIER on Track for 2026 Completion and Phase 2 Dose Selection

13-05-2026

yahoo.com

All You Need to Know About Aptevo Therapeutics (APVO) Rating Upgrade to Buy

20-05-2026

yahoo.com

Aptevo and Niowave Launch Strategic Collaboration for Radiopharmaceutical Therapeutic Development, Includes Strategic Equity Investment by Niowave at Closing

27-05-2026

yahoo.com

Aptevo Therapeutics Appoints Mary J. Janatpour, Ph.D., as Senior Vice President & Chief Scientific Officer

28-05-2026

yahoo.com

APVO: Initiating Coverage of Aptevo Therapeutics Inc.; Unlocking the Next Generation of Multispecific Immune Engagement

16-06-2026

yahoo.com

Aptevo Secures $1.5 Million Non-Dilutive Research Grant From the Andy Hill Care Fund to Advance APVO451, a Nectin-4-Targeted Trispecific Immunotherapy for Solid Tumors

30-06-2026

yahoo.com

APTEVO THERAPEUTICS INC (APVO:NASDAQ) Sentiment Trend

0 25 50 75 100 87 88 84 82 87 83 90 84 91 89 10-03-2026 19-03-2026 10-04-2026 06-05-2026 13-05-2026 20-05-2026 27-05-2026 28-05-2026 16-06-2026 30-06-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

APTEVO THERAPEUTICS INC (APVO:NASDAQ) FAQs

toggle

What is the current price of APTEVO THERAPEUTICS INC (APVO:NASDAQ)?

The current price of APTEVO THERAPEUTICS INC (APVO:NASDAQ) is $3.94.


toggle

APTEVO THERAPEUTICS INC (APVO:NASDAQ) absolute price change since previous trading day?

The absolute price change of APTEVO THERAPEUTICS INC (APVO:NASDAQ) since the previous trading day is $0.


toggle

APTEVO THERAPEUTICS INC (APVO:NASDAQ) percentage price change since previous trading day?

The percentage price change of APTEVO THERAPEUTICS INC (APVO:NASDAQ) since the previous trading day is 0%.


toggle

What is the most recent average sentiment score for APTEVO THERAPEUTICS INC (APVO:NASDAQ)?

The most recent average sentiment score for APTEVO THERAPEUTICS INC (APVO:NASDAQ) is 87 out of 100.


toggle

What is the most recent average sentiment for APTEVO THERAPEUTICS INC (APVO:NASDAQ)?

The most recent sentiment for APTEVO THERAPEUTICS INC (APVO:NASDAQ) is .


SEC-8K** Filing Available For APTEVO THERAPEUTICS INC (APVO:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.